Revolutionizing cancer therapy: Monoclonal antibodies in radiosensitization

Abolfazl Bemidinezhad ^1,2,3, Yasaman Abolhassani ⁴, Mojgan Noroozi-Karimabad ¹, Arman Abroumand Gholami ⁵, Abbas Alalikhan ^3,6,7, Ramin Roshani ⁸, Mohammad Parsa-kondelaji ⁹, Fatemeh Gheybi ^4,10 *

Cited by CrossRef: 0

1- Mahdi E, Alalikhan A, Ridha-Salman H, Azeez Ameen M, Hannon Abbass Z, Bemidinezhad A, Soukhtanloo M. Perfluorocarbon nanotechnologies for blood-brain barrier modulation: Enhancing drug delivery and neuroprotection. Biochemical and Biophysical Research Communications. 2025;789:152843 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons